Company: DERM
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001104659-25-041214
Chunk: 40

Company: Journey Medical Corp
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 40
---
 NEOs shown in our Summary Compensation Table; and • all current directors and NEOs as a group. As of the Determination Date, there were 17,113,604 shares of our common stock outstanding and 6,000,000 shares of Class A common stock outstanding. We have determined beneficial ownership in accordance with the rules of the SEC, which generally means that a person has beneficial ownership of a security if he, she or it possesses sole or shared voting or investment power of that security, including options and warrants that are currently exercisable or exercisable within 60 days of the Determination Date. “Voting power” is the power to vote or direct the voting of shares and “investment power” includes the power to dispose or direct the disposition of shares and “investment power” includes the power to dispose or direct the disposition of shares. Unless otherwise indicated, to our knowledge, the persons and entities named in the table below have sole voting and sole investment power with respect to all shares of common stock that they beneficially own, subject to community property laws where applicable. The information in the table below does not necessarily indicate beneficial ownership for any other purpose, including for purposes of Section 13(d) of the Exchange Act. Unless otherwise indicated, the address of each beneficial owner listed in the table below is c/o Journey Medical Corporation, 9237 E Via de Ventura Blvd. Suite 105, Scottsdale, AZ 85258.

| Name and Address of Beneficial Owner                        | ​ | ​ | Number ofShares ofCommon StockBeneficiallyOwned |   |           |   | ​ | ​ | Percentage ofCommonStock |   |        |   | ​ |
| Five percent or more beneficial owners                      | ​ | ​ | ​                                               | ​ |         ​ | ​ | ​ | ​ | ​                        | ​ | ​      | ​ | ​ |
| Fortress Biotech, Inc.(1)                                   | ​ | ​ | ​                                               | ​ | 9,860,467 | ​ | ​ | ​ | ​                        | ​ | 42.66% | ​ | ​ |
| Tang Capital Management LLC(2)                              | ​ | ​ | ​                                               | ​ | 1,523,938 | ​ | ​ | ​ | ​                        | ​ | 6.59%  | ​ | ​ |
| Named Executive Officers and Directors                      | ​ | ​ | ​                                               | ​ |         ​ | ​ | ​ | ​ | ​                        | ​ | ​      | ​ | ​